Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
Li Zhang, Zhimin Cui, Qianqian Li, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 985
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
Li Zhang, Qianqian Li, Ziteng Liang, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 1-5
Open Access | Times Cited: 374
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 99
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 91
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Zhenlu Chong, Courtney E. Karl, Peter Halfmann, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110799-110799
Open Access | Times Cited: 65
Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
Bao‐Zhong Zhang, Huiping Shuai, Hua‐Rui Gong, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 43
Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
Wei Zhang, Ke Shi, Qibin Geng, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 44
Open Access | Times Cited: 41
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 16
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
SARS‐CoV‐2 and natural infection in animals
Xinyu Qiu, Yi Liu, Ailong Sha
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 31
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3521-3539
Open Access | Times Cited: 29
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
Clare L. Fasching, Venice Servellita, Bridget McKay, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 7
Open Access | Times Cited: 29
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
Yongjing Xie, Michael Butler
Glycobiology (2023) Vol. 33, Iss. 3, pp. 188-202
Open Access | Times Cited: 18
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
Idowu B. Olawoye, Paul E. Oluniyi, Judith U. Oguzie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern
Nabanita Mandal, Aditya K. Padhi, Soumya Lipsa Rath
Journal of Molecular Graphics and Modelling (2022) Vol. 114, pp. 108194-108194
Open Access | Times Cited: 25
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
Comparative characterization of SARS‐CoV‐2 variants of concern and mouse‐adapted strains in mice
Qi Chen, Xing‐Yao Huang, Yu Liu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3223-3232
Open Access | Times Cited: 21
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Jing Zhang, Zi Bo Han, Yu Liang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 21
SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells
Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 19
The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
Cheng Zhang, Huan Cui, Entao Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10
Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
Anna Goc, Aleksandra Niedzwiecki, Vadim Ivanov, et al.
European Journal of Microbiology and Immunology (2022) Vol. 11, Iss. 4, pp. 87-94
Open Access | Times Cited: 16
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Hong Zhou, Wei‐Jian Ni, Wei Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
Abigael Chaouat, Ilija Brizić, Paola Kučan Brlić, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104935-104935
Open Access | Times Cited: 16
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain
Jiajing Wu, Jianhui Nie, Li Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top